Trinity Biotech (NASDAQ:TRIB) specializes in the development, manufacture, and marketing of clinical diagnostic products for the healthcare industry. Its offerings cater to the segments of infectious disease, clinical laboratory, and point-of-care. Trinity Biotech is traded on the NASDAQ under the symbol TRIB. The company aims to innovate and expand its diagnostics portfolio, focusing on enhancing healthcare outcomes by providing rapid, reliable testing solutions. With operations and strategic partnerships worldwide, Trinity's projects include advancing diagnostic technologies, improving existing product lines, and achieving operational excellence to meet the evolving needs of the global healthcare market.